Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Approved
Current status date:
2023-11-08
Product name:
ASPARLAS
DIN:
02542943
Product Monograph/Veterinary Labelling:
Date:
2024-03-08
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
SERVIER CANADA INC
270
3224 Avenue Jean-Béraud
Laval
Quebec
Canada
H7T 2S4
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Schedule D , Prescription
American Hospital Formulary Service (AHFS): See footnote 3
10:00.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
L01 ANTINEOPLASTIC AGENTS
Active ingredient group (AIG) number:See footnote5
0165262001
Active ingredient(s) | Strength |
---|---|
CALASPARGASE PEGOL | 3750 UNIT / 5 ML |